" Global Wound Biologics Market 2016-2020 " is the latest addition to MarketResearchReports.Biz industry research reports collection.
About Wound Biologics
Mechanical, chemical, thermal, and radiogenic damages can cause cuts, tears, and punctures in the skin, blood vessels, nerves, muscles, internal organs, bones, and joints. Wounds are of two types: acute and chronic. The reparative process in acute wounds occurs at a predictable and expected rate leading to faster healing, while it fails to occur in a predictable amount of time in chronic wounds.
Biologic wound healing process helps re-establish the innate repair mechanisms and may involve the application of biological agents such as plant-derived active biomolecules having antimicrobial, antioxidant, and anti-inflammatory attributes. Biologic dressings prevent evaporative water loss, protein and electrolyte loss, heat loss, and wound contamination. Wound biologics such as granular wound beds permit autolytic debridement for the healing process.
Technavios analysts forecast the global wound biologics market to grow at a CAGR of 20.63% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global wound biologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of:
Skin substitutes
Growth factors
Download Sample copy of this Report @
http://www.marketresearchreports.biz/sample/sample/560970
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Wound Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Acelity
Integra LifeSciences
Organogenesis
Smith & Nephew
Other prominent vendors
Avita Medical
BioDlogics
ConvaTec
Cytori Therapeutics
Intercytex
MacroCure
Molyncke Health Care
Market driver :Prevalence of chronic diseases
Market challenge :Limited availability of clinical data
Market trend :Advances in technology
Share: